Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the Intravenous Solutions market grown in recent years?

In recent times, there has been significant growth in the market size of intravenous solutions. The market, which was worth $14 billion in 2024, is projected to expand to $15.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Various factors driving this increase during the historic period include the upsurge in surgical procedures, escalating incidences of chronic diseases, wider reach of home healthcare services, strict regulations promoting product safety, a heightened emphasis on patient hydration, and worldwide initiatives for emergency preparedness.

How is the intravenous solutions market size expected to evolve during the forecast period?

Anticipated to witness significant expansion in the upcoming years, the intravenous solutions market is projected to escalate to $20.51 billion by 2029, resulting from a compound annual growth rate (CAGR) of 8.0%. The surging growth during the forecast period is ascribed to factors such as rising population and aging, a surge in surgical procedures, escalating cases of infectious diseases, advancements in telemedicine and remote patient surveillance, emphasis on preventive healthcare, investments in global health security, and a shift towards patient-focused care. Key trends anticipated during the forecast period encompass heightened demand for parenteral nutrition solutions, an acceleration in the adoption of pre-mixed intravenous solutions, broadening of home infusion therapies, the launch of electrolyte-balanced solutions, the advent of innovative drug additives and supplements, and the incorporation of intelligent intravenous systems for monitoring.

Get your intravenous solutions market report here!

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Which key drivers are propelling the intravenous solutions market’s growth?

The intravenous solutions market is anticipated to grow owing to the rise in cancer prevalence. Cancer, characterized by the uncontrolled growth of cells and their potential to invade nearby tissues and spread to other body parts, is witnessing a surge. Intravenous solutions are frequently utilized in cancer care for the delivery of chemotherapy drugs and to maintain hydration during the treatment. For example, the World Health Organization, a Switzerland-based intergovernmental agency, predicted in February 2024 that there would be over 35 million new cancer cases by 2050, a 77% increase from the estimated 20 million cases in 2022. As a result, the escalating prevalence of cancer is stimulating the intravenous solutions market’s growth.

Driver of Intravenous Solutions Market: The Surge in Surgical Procedures Accelerates Growth in Intravenous Solutions Market

What are the market segments in the intravenous solutions industry?

The intravenous solutions market covered in this report is segmented –

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients

3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution

4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

Which leading companies are shaping the growth of the intravenous solutions market?

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

What key trends are currently impacting the intravenous solutions market’s development?

Leading firms in the intravenous solutions market are concentrating their efforts on devising innovative syringes, such as ready-to-use and pre-filled ones, in order to maintain a competitive advantage. These syringes, which are already filled with medication and designed for immediate use, do not require any manual filling or preparations. For example, GENIXUS Corp., a healthcare company based in the US, introduced the KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes in August 2023. These syringes, crafted out of clear, sturdy polymer, remove the risk factors related to glass syringes. They are pre-filled and set for use, leading to time efficiency and minimizing medication errors. Rocuronium bromide injection is exclusively for intravenous use. It exhibits several essential features such as compatibility with KitCheck via RFID, the latest in kit and tray management technology, easy-to-understand labeling, and a color-coded plunger rod to facilitate quick identification.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

Which geographic areas are influencing the growth of the intravenous solutions market?

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

eClinical Solutions Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/eclinical-solutions-global-market-report

Care Management Solutions Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/care-management-solutions-global-market-report

Connected Health and Wellness Solutions Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/connected-health-and-wellness-solutions-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: